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ABSTRACT 
 
Dendritic cells (DCs) are essential for the development of an immune response 
against pathogens such as Listeria monocytogenes and Salmonella typhimurium. 
This is mostly because of their unique capacity to stimulate naïve T cells. Before 
DCs become potent antigen presenting cells, they undergo a maturation process that 
enables them to efficiently stimulate naïve T cells. This process includes 
upregulation of costimulatory molecules such as CD80 and CD86 and production of 
cytokines. However, the pathway by which DCs mature can influence their capacity 
to induce effector functions in T cells. Thus, the aim of this thesis was to investigate 
the maturation and function of DCs during intracellular bacteria infection and its 
impact on T cell stimulation. 
Conventional DCs expanded in number and upregulated costimulatory 
molecules in a subset- and tissue-specific manner after oral Listeria infection. 
Moreover, plasmacytoid DCs also expanded and upregulated CD86 and MHC-II 
although showing no tissue specificity. Conventional DCs produced significant 
amounts of IL-12. In addition, a complex CD11c-expressing population was 
identified, stratified in several subsets defined by production of TNF-α, iNOS and 
IL-12 alone or in combination. The production of these molecules was dependent 
on the subcellular compartment where Listeria was localized. Upregulation of 
CD80 and CD86 in DCs during orally acquired Listeria was differentially 
dependent on MyD88 and IFN-αβR. However, when the bacteria reached the blood 
stream directly, alternative pathways not mediated by MyD88 and IFN-αβR 
induced upregulation of costimulatory molecules. Remarkably, IFN-αβR-/- mice 
expressed higher levels of CD80 and CD86, which translated into stronger naïve T 
cell stimulation. However, despite the significance of IFN-αβR in the early anti-
Listeria response, it had little impact in the development of memory T cells. 
Similar to Listeria, expression of costimulatory molecules during 
Salmonella infection was only partially dependent on MyD88 and IFN-αβR. 
Expression of CD80 was controlled by MyD88, whereas the MyD88-independent 
upregulation of CD86 was supported by IFN-α/β. Furthermore, Salmonella-
associated DCs upregulated CD86 and CD80 to some extent even in the 
simultaneous absence of both MyD88 and IFN-αβR. However, DCs that matured 
by direct contact with the bacteria, but in the absence of these two factors, were less 
competent at stimulating naïve T cells than their wild type counterpart due to a 
decreased capacity to process bacteria-derived antigens. 
Taken together, these studies expand our understanding of DC function 
during bacterial infection. In addition, the identification of factors involved in DC 
maturation addressed here can help to design more efficient approaches in the 
future to eliminate bacterial infections. 
 
Keywords: Listeria, Salmonella, dendritic cells, maturation, MyD88, IFN-α/β 
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INTRODUCTION 
 
 
 
Evolution imposes the challenge of the coexistence of many different forms of 
life. In some cases, peaceful coexistence turns into survival battles. This is the 
case of numerous microorganisms that constantly invade others. Humans, in an 
effort that could be defined as intelligent evolution, have used these 
microorganisms to understand how they invade us and, more importantly, how 
to prevent and eliminate these unwanted invasions. The use of some particular 
microorganisms, such as intracellular bacteria, has been of great significance in 
understanding this process. From these studies, we have learned that our most 
important self-preserving system is what we now know as the immune system. 
This system, although one of the most complex and refined in our body, can be 
divided into two main subsystems: the innate and the acquired immune system.  
 Each of these systems has its own cellular and soluble components that 
help to recognize and eliminate harmful processes such as microbial infections 
or tumors. The innate immune system reacts quickly to microbial invasion 
whereas the response of the acquired immune system takes longer. However, in 
the event of a second exposure to the same infection, the acquired immune 
system can remember the first encounter and reacts more promptly. 
The cellular network of the innate immune system is mainly integrated 
by phagocytes. Some of these cells have the capacity to engulf material to be 
presented for recognition to cells of the acquired immune system. This 
interaction is a critical process in the development of an effective acquired 
immune response. In this thesis I use Listeria monocytogenes and Salmonella 
typhimurium to study the immune response against intracellular bacteria. Both 
Listeria and Salmonella are food-borne bacteria with a peculiar mechanism of 
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invasion that makes them very useful tools to understand the function of the 
immune system during intracellular bacterial infection. The role of one of the 
most important cells of the innate immune system, dendritic cells (DCs), in 
response to these bacteria, as well as their interaction with T cells, is the main 
focus of this thesis. 
 
 
Listeria and Salmonella as infection models 
 
Listeria and Salmonella share some pathogenic features, but also have many 
differences. As mentioned above, they are both intracellular bacteria. However, 
they have a very different life cycle inside a host cell. As a consequence of their 
particular mechanisms of evasion, the ensuing immune response has some 
properties unique to each pathogen. Table 1 summarizes some of the similarities 
and differences between these two microbes, which will be subsequently 
discussed. 
 
The Gram Slam 
Bacteria are one of the most common infectious agents known to date. The 
general classification of bacteria had its first breakthrough in 1884 when Hans 
Christian Gram published a staining method that could distinguish two large 
classes of bacteria (1). Bacteria that stain positive for Gram’s stain contain a 
cell wall rich in peptidoglycans. These peptidoglycans are associated with the 
cytoplasmic membrane by lipoteichoic acids. On the other hand, Gram-negative 
bacteria have a thin inner wall also containing peptidoglycans adjacent to the 
cell membrane. However, an outer wall rich in lipopolysaccharides (LPS) 
surrounds the thin, peptidoglycan-containing inner wall. In contrast, Gram-
positive bacteria lack LPS. Despite the obvious limitations of the Gram method 
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in the identification of specific bacteria, it remains useful today due to its ability 
to distinguish them based on the main components of their cell wall. 
 
Table 1. Properties of Listeria and Salmonella and features of the immune response 
against them 
 Listeria Salmonella 
Classification Gram-positive Gram-negative 
Natural route of 
entry 
Oral Oral 
Life cycle Intracellular, escapes the 
phagocytic vacuole 
Intracellular, colonizes the 
phagocytic vacuole 
Immunodominant 
antigen 
Listeriolysin O Flagellin 
Immunostimulatory 
molecules 
Peptidoglycans, 
Lipoteichoic acid, DNA 
LPS, Peptidoglycans, 
DNA 
Important 
cytokines 
TNF-α, IL-12,  
IFN-γ, IFN-α/β 
TNF-α, IL-12,  
IFN-γ 
Innate cells Monocytes, Neutrophils, Macrophages, DCs 
Acquired immune 
response 
Dominated by  
CD8 T cells 
Dominated by  
CD4 T cells 
 
Listeria monocytogenes 
Listeria is a Gram-positive bacterium that poses a risk to certain groups in the 
human population, such as pregnant women, neonates and immunodeficient 
individuals. Since the bacteria is most often spread by the oral route, the first 
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symptoms may include nausea and diarrhea. In more serious complications, the 
bacteria can spread to the central nervous system and cause meningitis. In 
pregnant women, severe listeriosis can lead to miscarriage, stillbirth, premature 
delivery or infection of the newborn (2).  
 Despite being a serious threat to the groups mentioned above, the wide 
use of Listeria as an infection model arises mostly from the fact that mice 
infected with the bacteria develop a typical granulomatous disease. This 
infection and its resolution in animal models, which requires cellular immunity, 
could be compared to tuberculosis in humans (3). The safer manipulation of 
Listeria compared to Mycobacterium tuberculosis led to its increasing use as 
infection model in mice. Thus, since Mackaness first adopted Listeria as an 
infection model in the 1960s (4), it has helped to unravel many of the 
mechanisms of immunity against bacterial infection.  
 
The way of the rocket: the life cycle of Listeria in a host cell  
Listeria was first isolated from the blood of rabbits suffering of mononuclear 
leucocytosis and was originally named Bacterium monocytogenes (5). The 
bacteria, however, invade not only phagocytic cells such as monocytes, but 
virtually any nucleated mammal cell. A well-characterized intracellular cycle of 
Listeria begins with its attachment to, and internalization by, the host cell. In 
phagocytic cells a large battery of host receptors, that will be further discussed, 
aid these processes. In non-phagocytic cells, invasion can be mediated by 
bacterial invasins such as the internalins A and B. Invasion through internalin A 
is restricted to cells expressing E-cadherin, mostly epithelial cells (6), whereas 
internalin B mainly interacts with the hepatocyte growth factor receptor (7). 
Internalin A- and B-mediated entry into a cell is a specie-specific process. For 
example, internalin A binds E-cadherin of humans and guinea pigs, but not 
mice. Conversely, internalin B binds Met of humans and mice, but not guinea 
pigs (8, 9).  
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 Once a bacterium is internalized by the host cell, it can escape into the 
cytosol before being killed in a lysosome. This is mainly mediated by a pore-
forming cytolysin, listeriolysin O (LLO) (10, 11). In coordination with LLO, 
two other enzymes secreted by the bacterium, the phospholipases PI-PLC (12-
14) and PC-PLC (15, 16), complete the destruction of the constraining vacuole. 
Bacterial liberation into the host cytosol is followed by polymerization of actin 
filaments. This is mediated by a bacterial protein named ActA (17). The 
bacteria use host actin to move within the cytosol (17-19). The ultimate goal of 
the pathogen is to launch itself out of the infected cell and spread to neighboring 
cells in a direct cell-to-cell fashion. The image of Listeria launching itself into 
adjacent cells is not inaccurate, as actin filaments of the host cell visually 
resemble rocket-powered motion as illustrated in figure 1.  
 
Figure 1. Typical life cycle of Listeria, adapted from Tilney and Portnoy (17). In the 
inset, L. monocytogenes moves in the cytoplasm of Xenopus laevis eggs by harnessing 
the force provided by the polymerization of actin filaments. (From Dr. Tim Mitchison’s 
laboratory, Harvard University: http://mitchison.med.harvard.edu/research/researcharea. 
html?area=1). 
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Salmonella 
Several hundred species of enteropathogenic bacteria are currently grouped 
under the genus Salmonella. The taxonomy of the group is complicated and 
diverse, comprising species with a wide range of hosts and pathogenicity (20). 
However, all Salmonella have the same route of spreading by ingestion of 
contaminated food or water. Curiously, although Salmonella can indeed be 
found in salmon (21), its name rather comes from one of the two scientists that 
first isolated it from pigs in 1885, Daniel E. Salmon, who at the time mistakenly 
believed it was the causative agent of the swine plague (22). 
 In humans, infection with Salmonella will cause a variable degree of 
illness, ranging from mild enteritis to severe systemic infections, depending on 
the particular serovar. Salmonella enterica, subspecie enterica serovar Typhi (S. 
typhi) has adapted to infect humans and is the cause of typhoid fever, an 
infection that is, tragically, often lethal. Since S. typhi has evolved into a host-
specific pathogen, its transmission implicates ingestion of material 
contaminated with feces from infected people. Thus, typhoid fever is a health 
problem in places with poor sanitation. Partially because of this host-specific 
condition, another serovar of Salmonella, Salmonella enterica subspecie 
enterica serovar Typhimurium (S. typhimurium), emerged as a reliable 
bacterium to study Gram-negative bacterial infections in animal models. The 
fact that S. typhimurium causes a disease in mice that resembles typhoid fever in 
humans makes this bacterium an interesting model to understand the immune 
response against this type of infection (23).  
 
Salmonella injects its way into a host cell and remains in vacuoles 
Invasion of non-phagocytic mammal cells by Salmonella is a complex process 
that is not completely understood. However, some of the most important parts 
of this process have been revealed. Similar to other Gram-negative pathogens, 
Salmonella relies on specialized secretion systems to infect a host cell. The 
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most important secretion system of Salmonella is the type III secretion system 
(24). The function of this system is to inject effector molecules that promote 
internalization of Salmonella by the host. Some of these effector molecules, 
such as SipA and SipC, will facilitate bacterial engulfment by manipulating host 
cytoplasmic actin (25, 26). The changes induced by Salmonella in the 
eukaryotic cell are, however, reversible. Strikingly, the bacterium itself 
promotes the recovery of the normal cellular architecture after its internalization 
is complete (27). Once inside the host cytosol, engulfed in a vacuole that 
resembles an early phagosome, the bacteria will drive this vacuole away from 
maturation into a classical bactericidal compartment. Instead, Salmonella will 
interfere with this maturation process and turn the vacuole into a favorable 
niche for survival and replication (28). Thus, Salmonella’s strategy to survive 
within the host cell resides in preventing the internalized vacuole from 
becoming a degrading compartment. In contrast, Listeria escapes the vacuole 
before being killed.  
 
  
Front line defense: the innate immune system 
 
Once invading bacteria break through the intestinal barrier after oral infection, 
the fate of the bacteria inside the host will be the result of the coordinated action 
of different components of the immune system. The first line of defense against 
pathogens is provided by components of the innate immune system. Phagocytic 
cells, such as monocytes, macrophages and neutrophils are essential to control 
intracellular bacteria such as Listeria and Salmonella. Likewise, some of the 
molecules they secrete in response to the bacteria, such as TNF-α, IFN-γ, IL-12 
and iNOS, are fundamental [(29) and reviewed in (30-32)]. Furthermore, the 
use of infection models such as Listeria and Salmonella has greatly furthered 
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our understanding of one of the most important component of the innate 
immune system in the defense against microbes: the DCs. 
 
 
AC?DC 
“Another Cell/a Dendritic Cell”, in the semantic sense of “a different cell”, 
could very well describe the function of DCs. The classical notion of AC/DC 
(Alternate Current/Direct Current) means that something can function with 
either type of electricity. Such plasticity is also applicable to DCs, considering 
the diversity of the stimuli that influence their function. DCs were revealed to 
modern science in 1973 (33). Since then we have learned that DCs are the most 
potent antigen presenting cell (APC) of the immune system, due to their 
superior capacity to stimulate naïve T cells compared to other APCs such as 
macrophages and B cells (34-36). Thus, the knowledge accumulated about the 
function of DCs during inflammation and other immune responses has 
increased enormously during the last 3 decades. However, as is often the case in 
science, every piece of new information generates new questions. Many of the 
unresolved questions about DC’s plastic functionality arise from the fact that 
DCs are a population heterogeneous in phenotype and function.  
 
DC types 
In mice, the bulk population of DCs can be divided into two major categories 
depending on their phenotypic and functional properties: conventional DCs 
(cDCs) and non-conventional DCs. In addition, both kinds of DCs comprise 
more than one distinct subpopulation (figure 2).  
Among cDCs, two groups can be distinguished according to their 
migratory capacity, one that migrates to a draining lymph node after collection 
of antigens, such as Langerhans cells for example, and other that is tissue-
resident (37). Phenotypically, most murine cDCs can be identified by high 
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expression of the integrin CD11c and major histocompatibility complex (MHC) 
II molecules. Langerhans cells can be specifically recognized by expression of 
the C-type lectin langerin, a molecule that belongs to a family of important 
receptors (38, 39). In addition, several subsets of tissue-resident cDCs can also 
be identified by expression of surface molecules, such as CD8α and CD4 in the 
case of splenic cDCs for example (40). There is also evidence that the different 
cDC subsets can specialize in performing different functions. For example, 
under certain conditions CD8α+ DCs induce a TH1-polarized response whereas 
CD8α- DCs tend to induce a TH2 response (41-43). In addition, CD8α+, but not 
CD8α- DCs, preferentially stimulate cytotoxic T cells both by classical 
presentation of intracellular antigens (44) or by cross-presentation in MHC-I 
(45). In contrast, in a model system, it has been shown that the CD8α- subset 
surpasses the CD8α+ DCs in presentation on MHC-II molecules. This correlates 
with higher expression of proteins involved in the MHC-II presentation 
pathway (46).  
 Non-conventional DCs include plasmacytoid DCs (pDCs) and other 
cells with DCs features. In addition to their plasmacytoid morphology, pDCs 
exhibit surface markers that are typically present in other cell types like B220 
and Ly6C. They also express an intermediate level of CD11c and lack CD11b 
expression (47, 48). pDCs specialize in the production of type I interferons 
(IFN-α/β), particularly upon viral stimulation (49). Other cells with DCs 
attributes seem to be generated during inflammatory conditions. They have a 
mixed phenotype and appear to specialize in the production of molecules such 
as TNF-α, IL-12 and iNOS (50-53). 
Thus, the phenotypic diversity and functional specialization of DCs 
adds to the complexity of their study (figure 2). As a consequence, the 
investigation of DC function during infection with bacteria such as Listeria and 
Salmonella requires the assessment of different subpopulations, which may 
have a different role during bacterial infection.  
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Figure 2. Examples of DC subpopulations and their surface phenotype and functions. 
References: a. (54), b. (44, 45), c. (46), d.(49), e. (50-53) 
 
 
DC control of Listeria and Salmonella infection 
Intestinal and splenic DCs are infected in vivo by Listeria (55-57). Although 
DCs are not the main reservoir for the bacteria (55, 56), accumulation of 
Listeria in the spleen could be dependent on CD8α+ DCs (56). Consistent with 
their prominent role as T cell stimulators, rather than pathogen eliminators, DCs 
seem to be less efficient than macrophages at killing Listeria (58). Furthermore, 
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using an in vivo DCs ablation model, Jung et al demonstrated that DCs are more 
potent stimulators of naïve T cells than macrophages (36). In the same study, 
the authors show the requirement of CD11c-expressing cells in vivo in eliciting 
an anti-Listeria CD8 T cell response. 
DCs could access Salmonella acquired orally after bacteria traverse 
through specialized M cells (59) or directly by extending dendrites between the 
epithelial cell tight junctions (60-63). As in the case of Listeria, DCs are vital to 
initiate a T cell response during oral Salmonella infection (64) and DCs 
harboring Salmonella correlates with T cell stimulation ex vivo (64, 65). 
Furthermore, both Listeria and Salmonella induce profound changes in DC 
biology that influence their function as APCs. These changes include 
upregulation of costimulatory molecules (53, 55, 66, 67), production of 
inflammatory cytokines (53, 66, 68) and alteration of their tissue distribution 
and migratory pattern (64, 68, 69). Thus, DC contact with intracellular bacteria 
such as Listeria and Salmonella, or with bacteria-derived products, is strongly 
reflected in DC physiology. Some of these changes are part of the process of 
DC maturation, and will influence DC interaction with lymphocytes.  
 
Antigen presentation and DC maturation 
The ultimate function of an APC is to process a relatively complex antigen and 
present a fraction of it, a peptide, to the T cells. This interaction is the most 
important connection between the innate and the acquired immune systems. 
Antigens are presented by APCs in the molecular support called MHC. Several 
kinds of MHC molecules have been described. They are called classical 
molecules, such as MHC-I and MHC-II, and non-classical like, for example, 
CD1 molecules. MHC-I and II molecules present peptides in a process that is 
well characterized. Most cells are able to process and present antigens on MHC-
I molecules to stimulate CD8 T cells whereas stimulation of CD4 T cells 
through presentation on MHC-II molecules is restricted to APCs such as DCs. 
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But the presentation of the antigen is just the tip of the iceberg. The fate of the T 
cells after their interaction with a DC will depend on the maturation and 
activation state of the latter. Thus, in order to potently activate naïve T cells, 
DCs have to undergo a process of maturation simultaneous with antigen 
processing and presentation. 
 DC maturation involves profound changes in DC physiology. These 
changes include phenotypic and functional alterations that influence the 
outcome of the DC-T cell interaction. Among the phenotypic changes that are 
commonly associated with mature DCs are the upregulation of costimulatory 
molecules such as CD80 and CD86, as well as upregulation of CD40 and MHC-
II. Physiological changes include a transient increase in antigen sampling and 
processing, alteration of their migratory pattern, and secretion of soluble 
immunomodulators such as inflammatory cytokines (Reviewed in (70)). Thus, 
increased levels of costimulatory and MHC-II molecules have been used as a 
hallmark of DC maturation. However, these phenotypic changes do not 
necessarily translate into an increased capacity to stimulate T cells (70-73). 
Thus, it is important to highlight the distinction between phenotypic and 
functional maturation. As a consequence, future efforts aimed at identifying the 
mechanisms of DC maturation must address whether phenotypic changes 
influence the capacity of the DCs to induce T cell clonal expansion and effector 
functions.  
 
Pathways of DC maturation 
The profound changes that DCs undergo during the maturation process imply a 
complex regulation that is just beginning to be unveiled. As mentioned above, 
DCs can display phenotypic signs of maturation without the potential to induce 
T cell effector functions. A discrepancy between phenotypic and functional 
maturation has recently been associated with the pathway by which a DC enters 
the maturation cycle. For example, a DC that directly interacts with a microbial 
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product such as LPS becomes phenotypically and functionally mature. The 
latter includes production of cytokines and gaining capacity to induce effector 
functions in T cells (73). However, the direct maturation of DCs and its 
regulatory mechanism during infection with complex pathogens, such as 
intracellular bacteria, has not been addressed thus far and is one of the aims of 
this thesis.  
Some of the cytokines produced by DCs have the potential to promote 
phenotypic maturation of DCs that do not directly interact with the pathogen 
(70). In addition, DCs are not the only cells in the body that can sense 
pathogens or their related products. Other cells, such as epithelial cells, can also 
produce inflammatory cytokines in response to microbial stimulation, indirectly 
influencing the maturation of DCs. However, DCs that mature indirectly 
through cytokine stimulation appear to be insufficient at inducing full activation 
of naïve T cells. For example, using mixed bone marrow chimeric mice, Spörri 
et al (73) constructed a system in which half of the DCs in the mixed chimera 
could sense the microbial product while the other half did not. In this setting, 
the DCs that could not directly sense the microbial product matured only 
indirectly. The authors showed that indirectly matured DCs displayed typical 
phenotypic maturation including increased CD40, CD86 and MHC after 
exposure to LPS or CpG. Furthermore, the indirectly matured DCs promoted 
CD4 T cell clonal expansion, but the CD4 T cells were, however, devoid of 
helper function (72, 73).  
From these data several interesting and important questions arise. An 
obvious issue is whether there is biological relevance for the indirect maturation 
phenomenon. Due to the magnitude of the response of indirectly matured DCs, 
they may have a role in shaping the immune response. Although this must be 
tightly regulated they could, for example, induce effector functions in activated 
or memory CD4 T cells, possibilities not addressed in the work of Spörri et al. 
Indeed, inflammatory conditions enhance proliferation and differentiation of 
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activated CD4 T cells (74), and macrophages can efficiently stimulate activated, 
albeit not naïve, CD8 T cells (36). Thus, a possibility could be that the DCs that 
mature directly are the ones that stimulate naïve T cells to initiate the acquired 
immune response while those that mature indirectly have a supportive role at 
different stages of the infection. Alternatively, or even simultaneously, it could 
be a mechanism to induce tolerance to self-reactive clones of T cells more 
efficiently during infection and thus focus the immune response on the relevant 
foreign antigens (75, 76). Whichever the case, the existence of several 
possibilities warrants investigation of the mechanisms of both direct and 
indirect DC maturation. 
 
 
Pathogen recognition and DC maturation 
As discussed above, DCs can mature by direct recognition of microbial 
products or indirectly through the effect of inflammatory cytokines secreted 
upon exposure to the same microbial products. Thus, recognition of microbes 
and their products is an event intrinsically linked to DC maturation. DCs are 
equipped with a vast battery of receptors that efficiently recognize invading 
microorganisms. Some of the important receptor families are starting to be 
identified and characterized. Among these families, the Toll-like receptor (TLR) 
family is of crucial importance, due to the fact that TLRs can induce both direct 
and indirect DC maturation. 
 
TLR signaling: the Toll bridge at work 
Pathogenic microorganisms express a number of macromolecules inherent to 
their nature, commonly known as pathogen-associated molecular patterns 
(PAMPs). In turn, potential hosts can recognize these PAMPs through PAMP 
recognition receptors. Among these receptors, the TLRs contribute significantly 
to the orchestration of an efficient immune response against pathogens. TLRs 
INTRODUCTION 
 
 21
control the development of the immune response against pathogens by 
selectively triggering intracellular signals in response to specific PAMPs. These 
intracellular signals, when activated in DCs, critically contribute to their 
maturation into potent APCs. 
The TLR family comprises 11 identified members in mice that are 
widely distributed among APCs including DCs. Although not comparable to T 
and B cell receptors, TLRs bring considerable specificity to the innate immune 
system. Some of them can associate as heterodimers, or even with non-TLR 
membrane clusters, to further diversify their recognition potential (77-79). 
Table 2 summarizes mouse TLRs and some of their identified ligands. TLRs are 
located both at the cell surface and intracellularly in endosomes. Regardless of 
their cellular location, engagement of TLRs leads to activation of transcription 
factors that promote transcription of inflammatory cytokines (80) and 
upregulation of costimulatory molecules (81-83).  
 
Table 2. Murine TLRs and some of their ligands 
TLR Natural ligand (ref.) TLR Natural ligand (ref.) 
1 and 2 Tri-acyl lipopeptides (84) 7 Single stranded RNA (85) 
2 and 6 Di-acyl lipopeptides (86) 8 No natural ligand identified 
3 Double stranded RNA (87) 9 CpG DNA (88) 
4 LPS (89) 10 Not functional (90) 
5 Flagellin (91) 11 Profilin-like protein (92) 
 
Signal transduction from TLRs requires adaptor molecules. The protein 
MyD88 is the major adaptor molecule in the TLR signaling cascade (80). 
However, a MyD88-independent pathway, mediated by TRIF, makes an 
important contribution to TLR signaling. The TRIF pathway, which is activated 
by TLR3 and TLR4, results in the production of IFN-α/β (80). Thus, TLRs are 
key receptors in the identification of pathogens by the innate immune system. In 
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connection with this, TLRs also play an essential role in the maturation of DCs 
and activation of other APCs. Figure 3 summarizes some of the components in 
the intracellular signaling cascade of the most relevant TLRs in fighting 
infection with intracellular bacteria such as Listeria and Salmonella.  
 
 
Figure 3. Possible TLRs involved in bacterial recognition and their functions.  TLRs 2, 
4, 5, 6 and 9 have the potential to recognize intracellular bacteria such as Listeria and 
Salmonella. Heterodimers formed by TLR2 and TLR6 could be involved in recognition 
of Gram-positive bacteria whereas TLR4 could be more relevant during Gram-negative 
infections. TLR5 could recognize both flagellated Gram-positive and Gram-negative 
bacteria.  
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TLRs during Listeria and Salmonella infection 
Both Listeria and Salmonella express several PAMPs that can potentially be 
recognized by TLRs. In the case of Listeria, an important component of the cell 
wall, lipoteichoic acid, can be recognized with the involvement of TLR2 (93, 
94). Likewise, the major component of Salmonella’s outer membrane, LPS, can 
be recognized by TLR4 (89). In addition, both Listeria and Salmonella express 
flagellin and contain CpG motifs in their DNA, molecules that can be 
recognized by TLR5 and TLR9, respectively (88, 91). Intracellular flagellin can 
also be recognized by another family of receptors that will be further discussed. 
 Supporting an important role of TLRs in the response against Listeria, 
two coincident studies reported increased susceptibility of MyD88 knockout 
mice infected with this bacterium (95, 96). Infected MyD88-/- mice had 
diminished serum levels of important anti-Listeria cytokines such as IL-12p40 
and IFN-γ (95, 96). Moreover, production of TNF-α and iNOS was 
compromised in the spleen of Listeria-infected MyD88-/- mice (97), although 
serum levels of NO2- and NO3- were normal (95). In addition, MyD88-signaling 
mediates production of the antibacterial lectin RegIIIγ against oral Listeria (98). 
MyD88-/- mice are also more sensitive to Salmonella infection (99, 100). 
However, immunological parameters such as the cytokine profile are less 
studied in mice infected with Salmonella.  
 Infection with live virulent bacteria such as Listeria and Salmonella is a 
major challenge for the immune system. Thus, the existence of redundant 
mechanisms could be required to survive such threatening infections. Indeed, 
several studies agree that deficiency of a single TLR is not definitive in the 
outcome of an infection with either Listeria or Salmonella (95, 100, 101). As 
both bacteria express several PAMPs and have multiple mechanisms to subvert 
the immune system, it is not surprising that the response against them is not 
determined by a single receptor interacting with its ligand. Furthermore, despite 
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the importance of TLRs, increasing evidence highlights the significance of other 
families of receptors involved in the recognition of intracellular bacteria (102). 
 
Other receptors: NLRs and beyond 
Members of the nucleotide-binding oligomerization domain-like receptor 
(NLR) family recognize pathogens or their products that reach the host cell 
cytosol (103). The NLR family groups intracellular PAMP recognition 
receptors that activate different signaling pathways. One such pathway, 
triggered by Ipaf and NALP3, is the activation of inflammatory caspase (casp-
1) through assembly of a multiprotein complex called the inflammasome (104). 
Active casp-1 catalyzes the conversion of procytokines to active IL-1β and IL-
18, two potent inflammatory cytokines. An alternative pathway, initiated by 
Nod1 and Nod2, promotes direct transcription through activation of the 
transcription factor NF-κB (104). Similarly to the TLR-mediated pathways, this 
will result in an inflammatory response. 
NALP3-dependent activation of IL-1β and IL-18 by macrophages 
infected in vitro with Listeria indicates a possible role of NLRs during Listeria 
infection (104, 105). Moreover, Nod2-deficient mice are more sensitive than 
wild type mice to oral Listeria infection (106). In addition to NLRs, other thus 
far unidentified intracellular receptors may also mediate the anti-Listeria innate 
immune response (107-109). These receptors activate the innate immune 
system, inducing the expression of several genes such as those encoding IFN-
α/β, MHC-II and costimulatory molecules (108).  
Although less studied than during Listeria infection, receptors other 
than TLRs may also be involved in the innate defense against Salmonella. 
Recently, two groups reported Ipaf-mediated intracellular recognition of 
Salmonella flagellin in a TLR5-independent fashion (103, 110, 111). Casp-1 
activation through Ipaf-mediated flagellin recognition resulted in production of 
IL-1β and IL-18 (103, 110). It also remains possible that receptors other than 
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TLRs and NLRs can be involved in the host response against Salmonella, 
although this has not yet been reported.   
Other families of receptors different from TLRs and NLRs are also 
important for the innate immune system. This includes the C-type lectin 
receptor family and the RIG-I-like receptor family. Members of both families 
can induce DC maturation and activation of the immune system. However, the 
identified members of these families capable of inducing DC maturation are 
restricted to recognizing fungi (dectin-1 as a C-type lectin receptor) (112) and 
double-stranded RNA (MDA5 and RIG-I as Rig-I-like receptors) (113). This 
specificity makes these particular receptors less relevant in antibacterial 
responses. Despite this, it is apparent that several families of receptors coexist 
and cooperate (114) and need to be considered when studying DC maturation. 
Such redundancy in the system underscores the need to study multiple 
pathways, especially when assessing in vivo responses to bacteria and DC 
maturation. In particular, the relative contribution of TLR-mediated and TLR-
independent pathways to bacterial-induced DC maturation in vivo is an 
important issue that is not completely resolved at present and is a topic 
investigated in this thesis. 
 
 
Acquired defense against Listeria and Salmonella 
 
The role of the innate immune system is instrumental in eliminating both 
Listeria and Salmonella. A decisive step of this process is the initiation of an 
efficient acquired immune response. Both main cell types of the acquired 
immune system, T and B lymphocytes, are involved in eradicating these 
bacteria. However, although B cells have a role in eliminating both Listeria and 
Salmonella, (115-117), their impact is less significant when compared with the 
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input of T cells. Furthermore, due to their different life cycles, the extent and 
type of the T cell response against each of these bacteria is different. 
 
 
The T cell solution 
Complete elimination of Listeria mostly relies on the development of cytotoxic 
CD8 T lymphocytes (CTLs) (118). The proposed mechanisms for CD8 T cell-
mediated immunity are the elimination of infected cells via perforin and 
granzymes, and the production of cytokines such as IFN-γ to activate 
phagocytes (119). In addition to classical MHC-I restricted CD8 T cells, CTLs 
restricted to non-classical MHC molecules also contribute significantly. The 
best characterized non-classical MHC-I anti-Listeria response is the one 
restricted to the presenting molecule called H2-M3 (120). These molecules 
present bacteria-derived peptides that contain a formylated amino terminal 
methionine residue. H2-M3-restricted CD8 T cells are cytolytic, produce IFN-γ 
and are sufficient to confer protection against a primary infection (121-123). 
Although both kinds of CTLs are important and not redundant (124) successive 
bacterial challenges are mainly cleared by expansion of classic MHC-I-
restricted CTLs (125). The role of CD4 helper cells is less studied during 
listeriosis, but it is known that they contribute to providing a TH1 environment 
(30). Moreover, CD4 T cells seem to control the development of CD8 memory 
T cells against Listeria (126-128). 
In contrast to Listeria, the main population of T cells mediating 
protection against Salmonella is CD4 T cells. Both non-classical and classical 
MHC-I-restricted CD8 T cells are generated during Salmonella infection (129-
131). However, their overall contribution to protective immunity is much less 
than that of CD4 T cells. As discussed above, CD4 T cells are less relevant in 
primary exposure to Listeria, but if not present then, subsequent exposures are 
detrimental to the host (127, 128). In contrast, CD8 T cells are dispensable 
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during primary infection with Salmonella, but are important for the memory 
response (132).  
Thus, T cells are crucial for elimination of intracellular bacteria such as 
Listeria and Salmonella. Using these two bacteria as infection models, the 
knowledge about the generation of an immune response has extended 
considerably. Yet, the mechanisms regulating this process are still incompletely 
understood. In particular, the DC-T cell interface and the factors involved in DC 
maturation that in turn define the outcome of that interface, are largely 
unexplored. For example, despite the known importance of MyD88 in DC 
maturation, mice deficient in this adaptor molecule develop memory CD8 T 
cells against Listeria (133, 134). The features of this MyD88-independent 
mechanism remain unknown. Thus, understanding the relative contribution of 
multiple pathways on DC maturation, and the resulting consequences on DC 
interaction with other cells, is the focus of intense research and one of the aims 
of this thesis. 
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AIMS 
 
 
 
The overall aim of this thesis is to study DC function, with special focus on the 
maturation process, during infection with Gram-positive and Gram-negative 
intracellular bacteria. To tackle this, three projects were designed and 
conducted, and are represented by the three papers included in this thesis.  
 
Specific aims of the papers: 
 
Paper I. 
1. To characterize the expansion and expression of costimulatory and anti-
bacterial molecules by different DC populations during Listeria infection.  
2. To determine the influence of the intracellular compartment in which the 
bacteria is detected in the production of the anti-bacterial molecules. 
 
Paper II. 
3. To investigate the mechanism of Listeria-induced DC maturation by 
assessing the relative contribution of MyD88- versus IFN-αβR-derived 
signaling to DC-mediated T cell stimulation and development of T cell 
memory. 
 
Paper III. 
4. To determine the relative contribution of MyD88 and IFN-αβR in direct 
versus indirect maturation of DCs during Salmonella infection. 
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MATERIALS AND METHODS 
 
 
 
The following section comprises general procedures and materials used in the 
experiments performed to obtain the results described in the section “results 
and discussion” of this thesis. Specific materials and methods used for 
experiments not shown in this thesis but shown in the individual papers can be 
found in the paper’s respective material and methods section.   
 
Mice 
C57BL/6 mice were purchased from Charles River Laboratories (Sulzfeld, 
Germany). MyD88-/- mice, IFN-αβR-/-, OVA257-264 peptide-specific TCR 
transgenic mice (OT-I) and OVA323-339 peptide-specific TCR transgenic mice 
(OT-II), all on C57BL/6 background, were kindly provided by S. Akira, J. 
Demengeot, N. Lycke and S. Schoenberger, respectively. MyD88-/- and IFN-
αβR-/- mice were crossed to generate MyD88-/-IFN-αβR-/- double knockout 
mice (called DKO mice). Mice were bred and maintained at the Laboratory for 
Experimental Biomedicine at Göteborg University. Mice were provided food 
and water ad libitum. Experiments were performed with 8-12 weeks old mice. 
All animal experiments were carried out following protocols approved by the 
government animal ethical committee and institutional animal use and care 
guidelines. 
 
Bacteria 
Listeria monocytogenes strains 10403s (papers I and II), 10403s LLO- (EJL1) 
and 10403s ActA- (EJL2) (both used in paper I), as well as the wild type 10403s 
and the ActA- derivative expressing full length OVA (paper II) were all kindly 
provided by H. Shen. Bacteria were grown from glycerol stocks in Brain and 
MATERIALS AND METHODS 
 
 30
Heart Infusion medium overnight with shaking at 37°C. Bacteria from 
overnight cultures were centrifuged and resuspended in PBS (pH 7.4) at the 
desired final concentration. S. typhimurium χ8554, χ4550 expressing OVA-
GFP, and the eGFP-expressing SM022 strains were grown in Lennox (χ8554) 
or Miller’s Luria-Bertoni (OVA-GFP-χ4550, eGFP-SM022) broth overnight at 
37°C (paper III). Strains χ8554 and χ4550 expressing OVA-GFP were kindly 
provided by R. Curtis III and eGFP-SM022 was from A. Zychlinsky.  
 
Animal infections 
Paper I. When mice were infected orally they were first given 100 μl of 1% 
NaHCO3 followed 10 minutes later by administration of 2-6 x 109 CFU of wild 
type Listeria in 100-200 μl of PBS. In experiments where animals were infected 
iv, bacteria from overnight cultures were diluted in PBS and mice were given a 
single 150 μl injection in the lateral tail vein. Doses were 5 x 104 – 5 x 105 CFU 
for wild type Listeria, 3 x 106 – 1 x 107 CFU for ActA- Listeria and 5 x 108 – 5 x 
109 CFU for LLO- Listeria. This was done to achieve equivalent bacterial 
burdens with the different bacterial strains.  
 
Paper II. Oral administration of wild type Listeria to C57BL/6 mice was done 
as described for paper I. The different knockout mouse strains received different 
oral doses to achieve equivalent bacterial burdens at the time of sacrifice. 
C57BL/6 received 2 x 109 CFU, IFN-αβR-/- received 8 x 109 CFU and MyD88-/- 
received 2-8 x 107 CFU. In experiments where different mouse strains were 
injected iv with wild type Listeria or the OVA-expressing derivative, the doses 
administered were 2 x 103 - 3 x 104 CFU for C57BL/6 mice, 3 x 104 CFU for 
IFN-αβR-/- mice and 2-3 x 102 CFU for MyD88-/- mice. For experiments 
addressing the memory response, mice were infected iv with 5 x 106 CFU of 
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OVA-expressing ActA- Listeria followed by a challenge 4 weeks later with 2 x 
105 – 1 x 106 CFU of OVA-expressing wild type Listeria. 
 
Paper III. C57BL/6 received 2 x 108 CFU, IFN-αβR-/- received 2 x 108 - 1 x 
109 CFU and MyD88-/- and DKO mice received 2 x 106 - 107 CFU when 
infected orally with Salmonella χ8554. When IFN-αβR-/-, MyD88-/- and DKO 
mice were infected orally with eGFP SM022 Salmonella, doses were increased 
10-fold to increase the number of GFP+ events. 
In all experiments, the bacterial dose administered was determined by 
reading the optical density at 600 nm and was confirmed by viable plating on 
corresponding agar plates. Likewise, the bacterial burden in tissues analyzed 
was determined by plating serial dilutions of organ suspensions on agar plates at 
the time of sacrifice.  
 
Preparation of cell suspensions 
In initial experiments, single cell suspensions from the mesenteric lymph nodes 
(MLN) and spleen were prepared by digestion with 1.6 mg/ml collagenase type 
IV (Sigma-Aldrich, St. Louis, MO) and 2 mg/ml DNAse I (Sigma-Aldrich) in 
HBSS (Gibco, Life Technologies, Paisley, UK) for 45 minutes at 37°C. To 
study cytokine production in paper I, collagenase and DNAse were substituted 
by 0.45 mg/ml Liberase (135) (Roche, Basel Switzerland), and Liberase was 
used for the rest of the experiments. Tissue was disaggregated by repetitive 
pipetting and erythrocytes were lysed with a hypotonic solution of NH4Cl. The 
cells were washed and resuspended in RPMI (Gibco, Life Technologies) 
supplemented with 10% heat-inactivated FCS (Sigma-Aldrich). A fraction was 
stained with trypan blue (Gibco, Life Technologies) to calculate the number of 
viable cells by exclusion of the dye. 
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Cytokine detection by RT-PCR 
Mice were infected with 2-6 x 105 CFU Listeria and 20 hours later the spleens 
were collected. Spleens from infected and naïve mice (5 per group) were pooled 
and a single cell suspension was prepared as described above. CD11c-
expressing cells were separated using anti-CD11c magnetic beads and an 
AutoMACS (both from Miltenyi Biotec Bergisch Gladbach, Germany) 
following the manufacturer’s instructions. RNA from both the negative and 
positive fractions was extracted using TriPure (Roche, Basel Switzerland). 
Genomic DNA was removed with the DNA-free kit (Ambion, Austin TX) and 
the remaining RNA was quantified and stored at -70°C until used in the reverse 
transcription reaction. 1 µg of RNA was transcribed using the Reverse 
Transcription System kit (Promega, Madison, WI) followed by amplification of 
the cDNA. PCR was standardized and performed using products from Promega. 
Specific primers and their target gene are listed in table 3. IFN-α genes were 
targeted at conserved sequences with primers designed to amplify all known 
members of the family. 
 
Table 3. Primers for PCR amplification 
Target Sequence Size in bp (ref.) 
β-actin GTG GGC CGC TCT AGG CAC CAA 
CTC TTT GAT GTC ACG CAC GAT TTC 
540 (136) 
GAPDH TGC TGA GTA TGT CGT GGA GTC TA 
AGT GGG AGT TGC TGT TGA AGT CG 
602 (137) 
IL-12p40 CGT GCT CAT GGC TGG TGC AAA G 
CTT CAT CTG CAA GTT CTT GGG C 
452 (136) 
IFN-α 
 
ATG GCT AGG CTC TGT GCT TTC 
TCT GAT CAC CTC CCA GGC ACA 
500 (138) 
IFN-β CCA TCC AAG AGA TGC TCC AG 
GTG GAG AGC AGT TGA GGA CA 
353 (139) 
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Flow cytometry 
Single cell suspensions were stained in HBSS containing 3% FCS, 5 mM 
EDTA and 20 mM HEPES (Gibco Life Technologies). Samples were first 
blocked with anti-FcγRII/III monoclonal antibody (clone 2.4G2) for 15 minutes 
at 4°C.  Cells were washed, antibody cocktails were added and the cells were 
incubated for 20 minutes at 4°C. 7-aminoactinomycin D (7AAD, Sigma-
Aldrich) was always used to exclude non-viable cells, except when analyzing 
CFSE labeled T cells. 
A 5- or 6-color staining strategy was used to study pDCs. First, non-
viable cells were excluded using 7AAD. Subsequently, lymphocytes and 
CD11b-expressing cells were also excluded with a cocktail containing 
Allophycocyanin-conjugated anti- CD19, TCRαβ and CD11b. The remaining 
population was selected using anti-B220-PE-Cy7, anti-CD11c-FITC and 
biotinylated anti-Ly6C followed by streptavidin Allophycocyanin-Cy7. Thus, 
pDCs were identified as 7AAD-, CD19-, TCRαβ-, CD11b-, CD11cint, B220+, 
Ly6C+ cells. When expression of CD80, CD86 or MHC-II was assessed, cells 
were additionally stained with PE conjugated anti- CD80, CD86 or MHC-II.  
Detection of intracellular cytokines by FACS was assessed directly ex 
vivo. Cell suspensions in RPMI supplemented with 10% heat-inactivated FCS, 2 
mM sodium pyruvate, 20 M HEPES and 0.05 mM 2-mercaptoethanol (all from 
Gibco Life Technologies) were incubated for 4 hours at 37°C in the presence of 
5 μg/ml of Brefeldin A (Sigma-Aldrich). Cells were stained for surface 
molecules, fixed with 2% formaldehyde (HistoLab Products AB, Göteborg, 
Sweden) and resuspended in permeabilization buffer (HBSS containing 0.5% 
BSA, 0.5% Saponin and 0.05% Azide). The antibodies required were added and 
incubated for 30 minutes at room temperature. 
 Cells were processed on either a LSR I or LSR II flow cytometer (BD 
Biosciences, San Diego, CA) using Cell Quest or DiVa software, respectively 
(BD Biosciences). Data were analyzed using FlowJo software (Tree Star Inc, 
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Ashland, OR) for all experiments. 
 
Ex vivo T cell stimulation 
Mice were infected iv with OVA-expressing wild type Listeria and after 48 
hours, spleens were pooled and single cell suspensions were prepared (paper II). 
CD11c-expressing cells were magnetically enriched using anti-CD11c magnetic 
beads and an AutoMACS (Miltenyi Biotec). Cells were then stained and 
CD11chigh cells were sorted at low pressure using a FACSAria cell sorter fitted 
with a 100 µm nozzle and DiVa software (BD Bioscience). Purity was > 98.5%. 
CD8 T cells from OT-I mice were isolated using the CD8 T cell 
isolation kit from Miltenyi Biotec following the manufacturer’s protocol. The 
procedure always rendered > 85% purity. OT-I cells were labeled with CFSE by 
incubating 107 cells in 1 ml of 1 µM CFSE diluted in PBS for 8 minutes. The 
reaction was stopped by addition of 1 ml of FCS. The cells were washed twice 
and resuspended in culture media. DCs and CFSE-labeled OT-I cells were 
incubated in RPMI containing gentamicin in 96 round-bottom well plates. After 
3.5 days, co-culture supernatant was collected and stored at -20°C until assayed 
for IFN-γ content. The cells were harvested, stained and acquired in an LSR II 
flow cytometer. 
 
In vitro DC-T cell assay. 
Flt3L-producing melanoma cells (140) were expanded in RPMI medium 
containing gentamicin. Medium was replaced after 24 hours and supernatant 
was harvested at 72 hours and stored at -20°C to be used as a Flt3L-rich 
supplement during in vitro culture of the in vivo expanded DCs. The melanoma 
cells were harvested by incubating them with 0.05% of Trypsin and 0.053 mM 
EDTA (Invitrogen), for 5 minutes at 37°C. Trypsinization was stopped by 
addition of medium containing 10% FCS and cells were centrifuged for 5 
minutes. Cells were washed 3 times with PBS and resuspended in PBS at 2.5 x 
MATERIALS AND METHODS 
 
 35
106 cells/ml. Mice were injected with 0.25 x 106 live cells subcutaneously in 
each groin. Fourteen days later, spleens were removed, pooled and DCs were 
enriched using magnetic beads. The enriched CD11c+ fraction was incubated 
with Salmonella χ4550 expressing OVA-GFP in antibiotic-free medium 
supplemented with 50% Flt3L supernatant for 2 hours in 6-well low adherence 
plates (Corning Inc. Acton, MA). GFP+ cells were sorted as described above 
and serial dilutions were cultured with a fixed amount (256,000 cells) of CFSE-
labeled Ly5.1+ CD4+ OT-II cells. Culture conditions were as described above 
for the ex vivo T cell stimulations. 
 
Detection of cytokines in culture supernatants 
Culture supernatant from DC-OT-I cell co-culture (paper II) and DC-OT-II co-
culture (Paper III) was assessed for IFN-γ content using an IFN-γ ELISA set 
(BD Bioscience).  
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RESULTS AND DISCUSSION 
 
 
 
The role of pDCs during viral infections has been well documented (49). 
However, their potential involvement in non-viral infections has not been 
studied. I thus set out to address the role of pDCs during infection with the 
intracellular bacterium Listeria. Using 4-color FACS analysis I found evidence 
that pDCs were reacting to Listeria infection. That is, an increase in a 
population that was 7AAD-CD11cintB220+Ly6C+ was apparent in the MLN after 
3 days of oral Listeria inoculation (figure 4A). In addition, an increase in a 
population that was also CD11cint and expressed CD8α was noticeable in the 
spleen after 5 days of infection (figure 4B). Interestingly, increased expression 
of CD8α by pDCs after microbial stimulation had been published (141).  
 
 
Figure 4. Cells with features of pDCs increase during oral Listeria infection. A, 
B220+CD11cint cells increase in number in the MLN after 3 days of infection and 
stained positive for Ly6C, a molecule found in pDCs. B, CD8α+CD11cint splenocytes 
expand after 5 days of oral Listeria infection. The numbers in the histograms represent 
the percentage of Ly6C+ cells gated on CD11cint or CD11chi cells as indicated. 
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These data suggested that pDCs were rapidly expanding in response to 
orally acquired Listeria. However, careful analysis of these populations 
revealed that the CD11cint population also contained B and T cells, as some of 
the CD11cintB220+ cells were CD19+ and CD22+, and some of the 
CD11cintCD8α+ cells were TCRαβ+. Additional experiments using an antibody 
reported to be specific for pDCs (142), mPDCA-1, confirmed the complexity of 
analysis of surface markers on pDCs, as several cell types expressed the antigen 
detected by the antibody mPDCA-1 in infected tissues (figure 5). This is in 
agreement with data showing upregulation of the antigen recognized by another 
antibody characterized as being specific for pDCs on B cells and DCs activated 
with IFN-α (143). 
 
Thus, “pDC-specific” antibodies recognized other cells and did not 
reliably identify only pDCs. Despite this, a fraction of CD11cint cells that 
expanded in response to the infection were neither T cells nor B cells. In 
addition, anti-mPDCA-1 staining also indicated a potential increase of pDCs 
that could be masked by other cells with some shared phenotype. Thus, to be 
able to determine if typical pDCs were actually expanding in response to 
Listeria infection, I developed an exclusion strategy to eliminate T, B, and 
myeloid cells (figure 6 and figure 2A in paper I). 
Once a reliable strategy to identify pDCs was developed, I investigated 
if this population expanded during the course of orally acquired Listeria. 
Figure 5.  Dot plots show reactivity to the 
monoclonal antibody mPDCA-1 in naïve 
mice and mice infected orally with Listeria 3 
days earlier. Circular gates in the left dot 
plots indicate the pDC population in steady 
state conditions.    
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Contrary to our initial thought, pDCs did not increase in the MLN or the spleen 
of infected mice 3 days after infection. However, the pDCs number doubled by 
day 5 post infection in both organs and remained elevated even after clearance 
of the infection (figure 2B in paper I).  
 
 
Figure 6. Identification of typical pDCs in the spleen of naïve and mice orally infected 
with Listeria. A cocktail of anti- CD19, TCRαβ and CD11b antibodies was employed 
to exclude T, B and myeloid cells (left dot plots). Cells negative for this cocktail were 
subsequently analyzed for CD11c, B220 and Ly6C to identify CD19-TCRαβ-CD11b-
CD11cintB220+Ly6C+ pDCs. The numbers in the gates represent percentage of the 
populations. This figure is extracted from figure 2 in paper I. 
 
Simultaneous analysis of cDCs revealed a subset-specific, tissue-
specific expansion. In the MLN, the CD8α- subset increased the most, while 
little expansion was observed by the CD8α+ subset. In the spleen, the CD8α+ 
and the CD4-CD8α- subsets increased the most, relative to their respective level 
in naïve mice. Figure 7 summarizes the changes in pDCs and total cDCs in the 
MLN and spleen of orally infected mice. 
 
 
Figure 7. Diagram representing changes in 
pDCs and the total cDC population in the 
MLN and the spleen of mice over the course 
of a 19 day oral infection with Listeria. MLN 
cDCs peaked earlier than splenic cDCs. Both 
MLN and splenic pDCs peaked at day 5 post 
infection and remained elevated even after 
cDCs contracted.  
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 Next, upregulation of costimulatory molecules on cDCs and pDCs was 
investigated. Similar to the findings with cDCs expansion, CD80 and CD86 
were upregulated by cDCs in a subset-specific, tissue-specific manner. MLN 
cDCs upregulated both CD80 and CD86, whereas splenic cDCs preferentially 
upregulated CD86. In the MLN, CD8α- cDCs showed the maximal upregulation 
of CD80 and CD86, while the CD8α+ subset showed little increase. Similarly, 
splenic CD4+ (CD8α-) and CD4-CD8α- cDCs upregulated CD86 more than 5 
fold, whereas in the CD8α+ subset the increase was approximately 2 fold. In 
addition, MLN and splenic pDCs greatly upregulated CD86 and MHC-II, but 
not CD80 (figure 8 and figures 3, 4 and 5 in paper I).  
 
 
Figure 8. MLN and splenic cDCs upregulate costimulatory molecules in a tissue-
specific, subset-specific manner while pDC upregulate CD86 and MHC-II similarly in 
both organs. The gray bars indicate upregulation of CD86 and CD80 in MLN CD8α- 
cDCs. Upregulation of these molecules on the CD8α+ subset was minimal in the 
MLN.Black bars indicate upregulation of CD86 by three different splenic cDC subsets 
after 3 days of oral Listeria infection. Upregulation of CD80 in the spleen was marginal. 
The open bars indicate upregulation of CD86 and MHC-II on splenic pDCs. MLN 
pDCs showed a similar trend (not shown). Expression of CD80 was not increased on 
pDCs after infection. The dashed line represents naïve levels. This figure is a summary 
of the data shown in figures 3, 4 and 5 of paper I. 
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I next investigated additional features of DC maturation by assessing 
their cytokine production. Furthermore, I wished to explore the impact of the 
bacteria-host interface in the production of the cytokines. To this end it was 
necessary to use the LLO- and the ActA- Listeria mutants. These two deficient 
bacteria are less virulent than wild type Listeria. Since simultaneous analysis of 
mice infected with LLO-, ActA- or wild type Listeria was desired, it was 
necessary to obtain mice with a similar bacterial burden in the tissue analyzed, 
regardless of the strain used for infection. It was practically not possible to 
increase the dose of the mutant bacteria, particularly LLO- Listeria, to recover 
similar numbers from orally infected mice. Thus, mice were infected iv. 
 
 
Figure 9. Increased expression of IL-12p40, IFN-α and IFN-β in CD11c-expressing 
splenocytes after 24 hours of iv Listeria infection. Dots plots show CD11c and B220 
expression in the positive and negative fractions of cells magnetically separated using 
anti-CD11c beads from 5 pooled spleens of naïve or Listeria-injected mice. The lower 
left gel shows amplification of IL-12p40 cDNA in the CD11c+ and CD11c- fractions, 
with and without reverse transcriptase for genomic DNA amplification control as 
indicated. To the right, amplification of IFN-α with universal primers (upper gel) and 
IFN-β (lower gel) is shown. 
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Initial experiments to detect cytokine production were performed by 
RT-PCR in CD11c-expressing cells magnetically enriched from the spleen of 
mice infected 24 hours earlier with wild type Listeria. The CD11c+ fraction 
contained both cDCs and pDCs (figure 9, dot plots). CD11c+ cells from infected 
mice showed increased expression of IL-12p40, IFN-α and IFN-β mRNA 
(figure 9). This approach provided initial evidence for DC cytokine production 
during Listeria infection. However, it was not optimal to identify which 
subpopulation (pDCs or cDCs) or cDC subset (CD8α+ or CD8α-) was 
producing the cytokines. 
Although the previous experiments raised the possibility that pDCs 
were producing IFN-α/β during Listeria infection, numerous attempts to detect 
the cytokine by intracellular FACS staining were unsuccessful. Conversely, 
cDCs production of IL-12p40 by both CD8α+ and CD8α- subsets was 
confirmed using FACS analysis (figure 6A and B in paper I). Furthermore, a 
CD11cint population different from pDCs that produced IL-12 and/or TNF-α 
was observed (paper I, figure 6C and D). The subset producing both TNF-α and 
IL-12 was not the same population described to produce TNF-α or iNOS (52), 
although they had a similar phenotype (figure 6E in paper I and (52)). Thus, 
these data suggest that an apparently homogeneous phenotypic population, 
which appears in response to acute listeriosis, consists of several different 
subsets characterized by functional specialization. The stratification of this 
population is represented in figure 10. 
 
 
Figure 10. Cells with 
similar phenotype but 
different function appear 
in the spleen of mice 
during acute (iv) Listeria 
infection.  
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Production of these antimicrobial molecules was differentially 
dependent on the potential of the bacteria to escape the host cell. Wild type 
bacteria induced production of TNF-α, IL-12 and iNOS by splenocytes while 
ActA- bacteria induced TNF-α and iNOS, albeit at lower levels than wild type 
bacteria, but not IL-12. Finally, when the bacteria had compromised capacity to 
escape the phagosome (LLO- mutant), none of the three molecules was detected 
(figure 8 in paper I). Thus, production of antimicrobial molecules by the host 
cell depends on the intracellular compartment where the bacteria is detected, as 
illustrated in figure 11. 
  
 
 
Next, the mechanism of costimulatory molecule upregulation during 
Listeria infection and its impact on T cell interaction was studied. As discussed 
previously, MyD88 is a major controller of bacteria-mediated DC maturation. 
In addition, other receptors that recognize Listeria induce production of IFN-
α/β (107-109). IFN-α/β is a complex family of cytokines that greatly influences 
the immune system. Among their functions, a role of IFN-α/β on DC 
Figure 11. Distinct regulatory levels 
of cytokine production during Listeria 
infection.  
 
1) Bacteria without the capacity to 
escape the phagosome (LLO-) do 
not induce TNF-α, iNOS or IL-12 
 
2) Bacteria that can escape the 
phagosome, but are unable to move 
by actin polymerization (ActA-), 
induce TNF-α and iNOS 
 
3) Wild type bacteria, able to escape 
the phagosome and to spread cell-
to-cell, induce TNF-α, iNOS and 
IL-12 
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maturation has been described under certain conditions (144). Furthermore, 
IFN-αβR-/- mice survive Listeria infection better than wild type mice (145-147), 
a somewhat surprising observation. Reduced bacteria-induced apoptosis was 
suggested as part of this mechanism (146). However, the impact of the lack of 
IFN-α/β signaling on DC maturation was not addressed in these studies. Thus, 
the obvious connection between Listeria recognition, MyD88 and IFN-αβR 
signaling, and DC maturation led us to study the contribution of these factors to 
DC immunocompetence during listeriosis (paper II). 
In the MLN, cDCs upregulation of CD80 was dependent on MyD88 but 
occurred independently of IFN-αβR after 3 days of oral Listeria infection 
(paper II, figure 1A). In contrast, upregulation of CD86 was independent of 
both factors. Using the same strategy to detect pDCs as described in figure 6, I 
found that upregulation of CD86 in this population was partially dependent on 
both MyD88 and IFN-αβR (figure 1B in paper II). CD80 was not upregulated 
by pDCs in response to oral Listeria (paper I). In contrast with the MLN, 
splenic cDCs and pDCs upregulated CD86 in a MyD88-dependent fashion 
(figure 2 in paper II). In agreement with the observations in paper I, no major 
changes in CD80 expression were observed. 
To rule out that the observed tissue specificity in the upregulation of 
CD80 and CD86 was related to the infection route, an iv route was subsequently 
used to mimic acute systemic infection without the complexity of bacterial 
traversal of the gastrointestinal barrier. When the bacteria reached the spleen in 
the absence of the mucosal barrier interface, CD80 and CD86 were upregulated 
independently of both MyD88 and IFN-αβR. Thus, the observation that cDCs 
from both infected MyD88-/- and IFN-αβR-/- mice could express high levels of 
costimulatory molecules led us to ask whether these signaling pathways would 
be needed simultaneously for this upregulation. To investigate this, MyD88-/-
IFN-αβR-/- (DKO) mice were generated. These mice lack all the thus far 
described bacteria-induced TLR signaling pathways to produce inflammatory 
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cytokines. In addition, signaling from IFN-α/β induced by other intracellular 
receptors (107-109) is also blocked in these mice. However, 48 hours after iv 
infection, C57BL/6, MyD88-/- and DKO mice show similar levels of 
costimulatory molecules. Interestingly, IFN-αβR-/- mice have higher expression 
of CD80 and CD86 (figure 12). 
 
 
Figure 12. DCs from Listeria-infected mice have enhanced costimulatory molecule 
expression. Upregulation of CD80 and CD86 in cDCs and pDCs from C57BL/6, 
MyD88-/-, IFN-αβR-/- and DKO mice 48 hours after iv Listeria infection is shown. The 
dashed line represents naïve levels. Bar graphs are from figure 3 in paper II. 
 
Thus, the increased level of CD80 and CD86 in infected IFN-αβR-/- 
mice, that is restored to wild type levels in the simultaneous absence of MyD88, 
suggests a role for IFN-α/β in the regulation of the immunostimulatory capacity 
of DCs. Indeed, the elevation in costimulatory potential is reflected in a higher 
capacity of cDCs from infected IFN-αβR-/- mice to stimulate antigen-specific 
CD8 T cells compared to cDCs from wild type animals (figure 13). 
The observation that IFN-α/β influences the costimulatory potential of 
DCs, and their capacity to activate naïve T cells, encouraged testing the 
hypothesis that a MyD88-independent anti-Listeria memory response could be 
mediated by IFN-α/β. 
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It has previously been published that MyD88-/- mice that survive 
Listeria infection are protected against secondary challenge (133, 134). Using 
OVA-specific MHC-I pentamers, I thus studied the development of anti-
Listeria memory CD8 T cells in MyD88-/-, IFN-αβR-/-, DKO and wild type 
mice infected with OVA-expressing Listeria. To ensure survival of MyD88-/- 
and DKO mice, animals were first infected with an OVA-expressing ActA- 
Listeria mutant. They were then challenged 4 weeks later with a fully virulent 
OVA-expressing Listeria strain. MyD88-/- mice developed lower numbers of 
specific memory CD8 T cells than IFN-αβR-/- and wild type mice (figure 14A). 
This defect was partially restored when mice simultaneously lacked MyD88 and 
IFN-αβR signaling (DKO mice, figure 14A). However, all four mouse strains 
efficiently cleared the challenge dose, which is lethal to naïve wild type mice.  
The function of the OVA-specific CD8 memory T cells was next 
analyzed. As shown in figure 14B, the ratio of TNF-α-producing memory CD8 
T cells generated in the DKO mice closely reflected the ratio of total OVA-
specific memory cell (figure 14A and B). However, the differences in IFN-γ-
producing, OVA-specific CD8 memory T cells were less dramatic than the 
difference in the ratio of total OVA-specific memory cell (figure 14A).  
Figure 13. Enhanced capacity of IFN-
αβR-/- DCs to stimulate CD8 T cells 
after Listeria infection. Symbols to the 
left show proliferation of OVA-
specific TCR transgenic CD8 T cells 
induced by cDC sorted from C57BL/6, 
MyD88-/- and IFN-αβR-/- mice 
infected 48 hours earlier with OVA-
expressing wild type Listeria. To the 
right the supernatant content of IFN-γ 
in the corresponding culture well is 
shown. Filled and open symbols of the 
same type correlate proliferation and 
IFN-γ content from the same wells.  
This figure summarizes data from 
figure 4 in paper II. 
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Figure 14. Diminished total memory CD8 T cells in MyD88-/- and DKO mice is 
compensated by IFN-γ-, but not TNF-α-, producing memory CD8 T cells. A. Infected to 
naïve ratio of total OVA-specific memory CD8 T cells after challenging with OVA 
expressing wild type Listeria C57BL/6, IFN-αβR-/-, MyD88-/- and DKO mice infected 4 
weeks earlier with OVA-ActA- Listeria.  B. Infected to naïve ratio of IFN-γ- and TNF-
α-producing OVA-specific memory CD8 T cells in the same mice. Bar graphs are from 
figures 5 and 6 in paper II. 
 
Thus, the ability to develop a normal pool of IFN-γ-producing, antigen-
specific CD8 T cells could explain the capacity of MyD88-/- mice to clear a 
secondary challenge with the bacteria. This, however, is not mediated by IFN-
α/β. Despite the role of IFN-α/β in the early response against Listeria, and its 
involvement in DCs immunostimulatory capacity, IFN-α/β seems to play a 
minor role in the development of an anti-Listeria memory response. This is 
apparent since DKO mice were as efficient as MyD88-/- mice at clearing 
secondary challenge with the bacteria. 
We next addressed the role of these two important signaling pathways 
in Salmonella-induced DC maturation (paper III), based on previous studies in 
our group suggesting that multiple pathways were involved in DC maturation 
during Salmonella infection (66). Similar to Listeria, orally administered 
Salmonella induced upregulation of CD86, but not CD80, on DCs in the MLN 
and spleen of infected MyD88-/- mice. However, the onset of this MyD88-
independent pathway required high bacterial load in the MLN (figure 15). 
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Figure 15. Upregulation of CD86 on CD8α- DCs from MyD88-/- mice after oral 
Salmonella infection. MyD88-independent upregulation of CD86 in the MLN requires a 
higher threshold of bacterial load. This figure highlights results from figure 1 in paper 
III. 
  
The MyD88-independent upregulation of CD86 on the bulk population 
of cDCs was indeed mediated by IFN-αβR signaling. Orally infected DKO 
mice failed to upregulate CD86 to levels shown by infected MyD88 deficient 
mice with similar bacterial burden (figure 3 in paper III). As only a very small 
percentage of DCs contain bacteria during infection, most of the DCs analyzed 
in the infected tissues are subject to indirect maturation through cytokine 
stimulation. We thus wanted to address the relative contribution of the MyD88 
and IFN-αβR signaling pathways on direct maturation of DCs by bacterial 
contact compared to indirectly matured DCs.  
To this end we infected MyD88-/-, IFN-αβR-/- and DKO mice with a 
GFP-expressing Salmonella. Remarkably, Salmonella-associated DCs (GFP+ 
DC) upregulated CD86 independently of both signaling pathways. In addition, 
CD80 was partially upregulated independently of these two factors. In sharp 
contrast, DCs non-associated with Salmonella (GFP- DC) were unable to 
upregulate costimulatory molecules (figure 16, see also figure 4A-C in paper 
III). 
 
CD8α- DC Bacterial 
load 
CD86 
upregulation 
SPLEEN ~105 High 
MLN ~105 Absent 
 >105 High 
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Figure 16. Salmonella-associated DCs upregulate CD86, and partially CD80, 
independently of MyD88 and IFN-αβR signaling. CD8α- DCs contained the highest 
number of bacteria in Peyer’s patches 2 days after oral administration of GFP-
Salmonella. This figure highlights results from figure 4 in paper III. 
 
This striking finding prompted us to ask whether DCs directly matured 
in the absence of MyD88 and/or IFN-αβR were competent stimulators of T 
cells. Focusing the experiments on Salmonella-driven direct DC maturation 
required access to a large number of Salmonella-associated DCs. To perform 
the experiments in figure 16, Peyer’s patches from 20 mice were pooled in 
order to collect enough GFP+ DC for reliable analysis. These numbers, 
however, were not sufficient for GFP+ DC-T cell co-cultures experiments. To 
increase the number of GFP+ DC it was therefore necessary to infect the mice 
iv. Thus, MyD88-/- and DKO mice were injected with a GFP-OVA-expressing 
Salmonella strain, and GFP+ DC were isolated and cultured with OVA-specific 
CD4 T cells. These experiments revealed that MyD88-/- and DKO GFP+ DC 
were less efficient than wild type GFP+ DC at inducing T cell proliferation and 
production of IFN-γ (figure 5 in paper III).  
To further investigate the mechanism, we compared the level of 
costimulatory and MHC-II molecules as well as some cytokines produced 
during infection between infected DKO and wild type mice. The defect in T cell 
stimulation could not be attributed to deficient expression of CD40, CD80, 
CD86 or MHC-II after iv bacterial administration (figure 6A in paper III). In 
CD8α- DC CD80 
upregulation 
CD86 
upregulation 
GFP+ Moderate High 
GFP- Absent Absent 
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addition, both DKO and wild type DCs induced equal T cell proliferation and 
IFN-γ production when loaded in vitro with OVA peptide (figure 6B in paper 
III). Moreover, infected DKO and wild type mice produced a similar amount of 
cytokines with potential to induce DC maturation, such as TNF-α and IL-1β. 
However, infected wild type mice produced 7 times more IFN-γ than DKO 
mice (paper III, figure 6 C). These data indicate defective antigen presentation 
capacity in the absence of MyD88, a situation that has recently been described 
in another infection model (92). We thus designed an in vitro experiment where 
the influence of external factors, such as cytokines and other non-DC cell 
derived input, were absent. To this end, DCs were Flt3L-expanded in vivo in 
DKO and wild type mice, magnetically enriched from pooled spleens and 
infected in vitro with GFP-OVA-Salmonella. Sorted GFP+ DKO DC induced 
lower T cell proliferation and IFN-γ production than their wild type 
counterparts (figure 17).  
 
 
 
Thus, based on our data we propose a multilayered model for the 
regulation of the expression of costimulatory molecules during Salmonella 
infection (figure 18). The first level of regulation, which has a higher impact on 
costimulatory molecule expression, particularly CD80, is controlled by MyD88-
derived signals. Second, in the absence of MyD88, IFN-α/β can ensure a high 
level of costimulatory molecules in the bulk population of DCs. A third level is 
Figure 17. OT-II cells 
proliferation and IFN-γ 
production induced by 
DCs infected in vitro with 
GFP-OVA-expressing 
Salmonella. Plots are from 
figure 6 in paper III. 
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inherent to DCs that come in direct contact with the bacteria. The latter, 
however, is not sufficient to induce full stimulation of CD4 T cells. 
 
 
 
Figure 18. Hierarchical model of DC maturation controlled by MyD88 and IFN-αβR 
signaling pathways during Salmonella infection. 1) MyD88-derived signals control 
upregulation of costimulatory molecules. 2) In the absence of MyD88, IFN-α/β 
maintains a high level of CD86 in the bulk DC population. 3) The combined deficiency 
of MyD88 and IFN-αβR abrogates expression of costimulatory molecules. 4) DCs 
matured by direct bacterial contact still upregulate CD86 and CD80 even in the absence 
of MyD88 and IFN-α/βR. However, this is not sufficient to induce full activation of 
CD4 T cells, and appears to be due to poor presentation of bacterial-derived antigens. 
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The main objective of this work was to study the function of different DC 
subpopulations during infection with Gram-positive and Gram-negative 
intracellular bacteria. A particular focus was to investigate possible differential 
responses for described DC subpopulations and subsets in eliminating the 
infections. Furthermore, special efforts were aimed at understanding the 
mechanism of bacteria-induced DC maturation. 
 The work in this thesis thus started by characterizing the expansion, 
costimulatory molecule expression and production of anti-bacterial molecules 
by cDCs, pDCs and DC-related, CD11c-expressing cells during Listeria 
infection. I found that cDCs expanded and upregulated costimulatory molecules 
in a subset-specific and tissue-specific manner. In contrast to cDCs, pDCs 
expanded simultaneously in the MLN and spleen of infected mice. They also 
upregulated CD86 to a level found in naïve cDCs. As part of the maturation 
process, cytokine production by DCs was studied. Contrary to the general belief 
that macrophages are the main producers of IL-12 during listeriosis (148), two 
different cell types were identified as the main source of this cytokine. One of 
them was cDCs. The other was a population with a mixed phenotype that 
expressed an intermediate level of CD11c and an intermediate to high level of 
Gr1, Mac3 and CD11b. The complexity of this population was apparent, as cells 
could produce TNF-α, iNOS and IL-12 alone or in specific combinations. 
Finally, I determined that the intracellular compartment where the bacteria are 
found was crucial for the production of these molecules, a situation that could 
have strong implications in the development of the specific T cell response 
(149-153). 
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I also found that expression of costimulatory molecules was dependent 
on MyD88 and IFN-αβR signaling at different degrees in pDCs and cDCs of 
mice orally infected with Listeria. In particular, CD80 expression was highly 
dependent on MyD88, whereas CD86 showed partial dependence on MyD88 
and IFN-αβR signaling. However, MyD88 and IFN-αβR dependence could be 
overcome by iv injection of the bacteria. Whether this is a mucosal-specific 
mechanism or is dependent of the number of bacteria seeding the organ at the 
time of analysis remains to be determined. Interestingly, iv infected IFN-αβR-/- 
mice showed increased upregulation of CD80 and CD86 compared to infected 
MyD88-/- and wild type mice. These values went down to MyD88-/- and wild 
type mice levels when IFN-αβR-/- mice simultaneously lacked MyD88-derived 
signaling (DKO mice). This suggests that IFN-α/β play a role in the regulation 
of costimulatory molecules, perhaps by downmodulating MyD88-derived 
factors. Whether IFN-α/β acts by downregulating the effect of MyD88-
dependent cytokines or directly interferes in the intracellular MyD88 pathway, 
downstream of the IFN-αβR-signaling cascade, are possibilities open to future 
investigation. The increased level of costimulatory molecules in DCs from 
infected IFN-αβR-/- mice translated into a higher capacity to stimulate T cells. 
Thus, the lack of IFN-α/β signaling had an impact on the innate response to 
Listeria. In contrast, it had only a minor effect on the generation of anti-Listeria 
memory CD8 T cells. 
 Similar to Listeria, Salmonella-induced upregulation of CD80 in DCs 
was largely dependent on MyD88. However, CD86 could be expressed at high 
levels in the absence of MyD88. This upregulation was mediated by IFN-αβR 
signaling, since the bulk population of DCs was unable to express high levels of 
costimulatory molecules in infected DKO mice. However, Salmonella-
associated DCs were able to upregulate CD86, and partially CD80, in the 
simultaneous absence of these two factors. Thus, DCs that mature by direct 
CONCLUSIONS 
 
 53
contact with the bacteria undergo an intrinsic maturation program that is 
independent of factors important for cellular signaling, such as MyD88 and 
IFN-αβR. Nonetheless, the immunostimulatory capacity of DCs that mature in 
the absence of these factors is not optimal and they have a compromised 
capacity to stimulate naïve T cells compared to their wild type counterpart. 
 Thus, the process of DC maturation is fundamental for the development 
of an efficient immune response. Accordingly, the dissection of the different 
factors involved in the regulation of this process is of extreme importance. The 
identification of this factors and their relative contribution could lead to the 
improvement of tools and strategies, such as new therapies and vaccine design, 
that can improve public health in the future. Overall, the work presented in this 
thesis broadens the knowledge on DC function and maturation during bacterial 
infection. It is also my conviction that every piece of information made 
available to the scientific community is an important contribution in our search 
to understand nature. Therefore, an important goal of this thesis will be fulfilled 
if the information gathered here is useful to other researchers in future 
investigations. 
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